2223 related articles for article (PubMed ID: 27077117)
1. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
2. Periphery Biomarkers for Objective Diagnosis of Cognitive Decline in Type 2 Diabetes Patients.
Liu Y; Zhang S; He B; Chen L; Ke D; Zhao S; Zhang Y; Wei W; Xu Z; Xu Z; Yin Y; Mo W; Li Y; Gao Y; Li S; Wang W; Yu H; Wu D; Pi G; Jiang T; Deng M; Xiong R; Lei H; Tian N; He T; Sun F; Zhou Q; Wang X; Ye J; Li M; Hu N; Song G; Peng W; Zheng C; Zhang H; Wang JZ
Front Cell Dev Biol; 2021; 9():752753. PubMed ID: 34746146
[No Abstract] [Full Text] [Related]
3. GSK-3β activation mediates apolipoprotein E4-associated cognitive impairment in type 2 diabetes mellitus: A multicenter, cross-sectional study.
Gao Y; Yu H; Liu Y; Xu Z; He B; Liu H; Wang Y; Zhang Y; Liang Y; Yang Y; Zheng J; Wang JZ
J Diabetes; 2024 Jan; 16(1):e13470. PubMed ID: 37700547
[TBL] [Abstract][Full Text] [Related]
4. Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patients.
Yu H; Liu Y; He T; Zhang Y; He J; Li M; Jiang B; Gao Y; Chen C; Ke D; Liu J; He B; Yang X; Wang JZ
Aging Cell; 2021 Oct; 20(10):e13469. PubMed ID: 34528736
[TBL] [Abstract][Full Text] [Related]
5. Strong Association of Serum GSK-3β/BDNF Ratio with Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients.
Du B; Lian Y; Chen C; Zhang H; Bi Y; Fan C; Bi X
Curr Alzheimer Res; 2019; 16(12):1151-1160. PubMed ID: 31453785
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
7. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
8. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
[TBL] [Abstract][Full Text] [Related]
10. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
11. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
[TBL] [Abstract][Full Text] [Related]
12. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
[TBL] [Abstract][Full Text] [Related]
13. ε3/4 genotype of the apolipoprotein E is associated with higher risk of Alzheimer's disease in patients with type 2 diabetes mellitus.
Tang Y; Li YM; Zhang M; Chen YQ; Sun Q
Gene; 2019 Jun; 703():65-70. PubMed ID: 30890475
[TBL] [Abstract][Full Text] [Related]
14. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
[TBL] [Abstract][Full Text] [Related]
16. Discovering new peripheral plasma biomarkers to identify cognitive decline in type 2 diabetes.
Yu H; Gao Y; He T; Li M; Zhang Y; Zheng J; Jiang B; Chen C; Ke D; Liu Y; Wang JZ
Front Cell Dev Biol; 2022; 10():818141. PubMed ID: 36506101
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
18. Association of CSF GAP-43 and
Zhu Y; Guo X; Zhu F; Zhang Q; Yang Y; For The Alzheimer's Disease Neuroimaging Initiative
Cells; 2022 Dec; 12(1):. PubMed ID: 36611808
[TBL] [Abstract][Full Text] [Related]
19. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.
Neu SC; Pa J; Kukull W; Beekly D; Kuzma A; Gangadharan P; Wang LS; Romero K; Arneric SP; Redolfi A; Orlandi D; Frisoni GB; Au R; Devine S; Auerbach S; Espinosa A; Boada M; Ruiz A; Johnson SC; Koscik R; Wang JJ; Hsu WC; Chen YL; Toga AW
JAMA Neurol; 2017 Oct; 74(10):1178-1189. PubMed ID: 28846757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
